drugset / Trial / NCT00017277
Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer
Phase 3
Terminated
47 enrolled
European Organisation for Research and Treatment of Cancer - EORTC
Charite University, Berlin, Germany · collabGroupe Oncologie Radiotherapie Tete et Cou · collabGrup per l'Estudi dels Limfomes de Catalunya i Balears · collabRadius Hungaricus Oncology Group · collabTrans Tasman Radiation Oncology Group · collab
RandomizedDouble-blindTreatment
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa may help prevent or treat cancer-related anemia. It is not yet known whether radiation therapy is more effective with or without epoetin alfa in treating head and neck cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without epoetin alfa in treating patients who have head and neck cancer.
Timeline
- Start
- 2001-03
- Primary completion
- 2003-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | Subcutaneous |